National Health Investors (NHI) M&A Presentation summary
Event summary combining transcript, slides, and related documents.
M&A Presentation summary
22 Apr, 2026Transaction overview
Announced sale of 32 skilled nursing and 3 independent living facilities for $560 million to the current lessee, with estimated transaction costs of $6–8 million.
Special Committee of independent directors approved the sale, retaining separate counsel and financial advisors.
Properties generated $39.7 million in cash lease revenue in 2025; proceeds will be used to repay debt and fund future investments, including potential 1031 exchanges.
Transaction expected to close July 1, 2026, pending customary conditions and regulatory approvals.
Impact on REIT distribution requirements to be determined in Q4 2026, with capital redeployment strategies in place.
Strategic rationale
Increases concentration in private pay senior housing, enhancing portfolio quality and value proposition.
Strengthens balance sheet by deleveraging and improving financial flexibility.
Positions for accelerated external growth and improved valuation potential.
Simplifies structure, reduces tenant concentration risk, and removes related-party dynamics.
Portfolio and financial impact
Pro forma senior housing and SHOP investments rise to 83.8% of total investment and 78.6% of annualized adjusted NOI.
Embedded organic growth expected in SHOP segment, with high single- to low double-digit internal growth projected.
Shift in portfolio concentration leverages superior valuation of private pay senior housing over skilled nursing.
Latest events from National Health Investors
- Annual meeting to vote on directors, executive pay, and auditor ratification for 2026.NHI
Proxy filing3 Apr 2026 - 2025 saw robust growth, board refreshment, enhanced governance, and expanded ESG initiatives.NHI
Proxy filing3 Apr 2026 - Normalized FFO per share rose 8.9% in Q4, with SHOP NOI up 125% and 2026 outlook strong.NHI
Q4 202527 Feb 2026 - Q2 FFO, FAD, and revenues rose, but net income fell; SHOP occupancy and guidance increased.NHI
Q2 20242 Feb 2026 - SHOP occupancy and NOI surged, but net income and FFO per share declined; liquidity remains strong.NHI
Q3 202416 Jan 2026 - Q4 and 2024 outperformed, with strong growth and 2025 guidance signaling further gains.NHI
Q4 20246 Jan 2026 - Proxy contest aims to overhaul board independence and governance, urging immediate declassification.NHI
Proxy Filing1 Dec 2025 - Strong financial results, board refreshment, and major governance reforms headline this year's proxy.NHI
Proxy Filing1 Dec 2025 - Board refreshment, strong financials, and governance reforms drive growth and shareholder value.NHI
Proxy Filing1 Dec 2025